{"id":"W4400930587","doi":"10.25251/skin.8.supp.404","title":"Bimekizumab Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Pooled Analysis from Up to 4 Years of Treatment in 5 Phase 3/3b Clinical Trials","year":2024,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Queen's University","funders":"UCB Pharma; Eisai; Torii Pharmaceutical; Amgen","keywords":"Tolerability; Plaque psoriasis; Medicine; Pooled analysis; Clinical trial; Psoriasis; Internal medicine; Dermatology; Adverse effect; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02955241,0.001947956,0.00833553,0.001732998,0.000550631,0.002356366,0.0009895118,0.001647278,0.003248328],"category_scores_gemma":[0.02063752,0.001080711,0.01951541,0.002634656,0.0007186168,0.001506125,0.001244815,0.001637299,0.0003846669],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008087939,"about_ca_system_score_gemma":0.001479099,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009362195,"about_ca_topic_score_gemma":0.001919172,"domain_scores_codex":[0.9839839,0.009702211,0.002145249,0.001856595,0.001753582,0.0005583937],"domain_scores_gemma":[0.9822043,0.00839549,0.006404351,0.001411039,0.0009913318,0.0005934015],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.368735,0.0006438054,0.05173836,0.02628519,0.4784368,0.0002257315,0.0001919098,0.004442587,0.003768858,0.0001926745,0.004126947,0.06121209],"study_design_scores_gemma":[0.1496677,0.03870286,0.2271052,0.003311298,0.5655434,0.0008952896,0.0001516761,0.00237247,0.001464676,0.001199726,0.00937254,0.0002133151],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5000407,0.4697998,0.00640691,0.000808954,0.0005493623,0.003627794,0.01322243,0.0004478175,0.005096242],"genre_scores_gemma":[0.9420878,0.04270517,0.002456027,0.0009000173,0.0005151928,0.003377282,0.006964036,0.0001072021,0.0008873593],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02955241,"threshold_uncertainty_score":0.1562899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04438970228239314,"score_gpt":0.3633234505643497,"score_spread":0.3189337482819565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}